Atrasentan, sold under the brand name Vanrafia, is a medication used to reduce proteinuria. It is an endothelin receptor antagonist. It is taken by mouth.
Atrasentan, sold under the brand name Vanrafia, is a medication used to reduce proteinuria. It is an endothelin receptor antagonist. It is taken by mouth.
Atrasentan was approved for medical use in the United States for IgA nephropathy in April 2025.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).